ERBB2 and neoplasm: 225Ac-labeled nanobodies such as [225Ac]Ac-DOTA-Nb have shown fast uptake in tumor-bearing mice with HER2-overexpressing tumors, with coinjection of Gelofusine reducing kidney retention by 70% [95].